437 related articles for article (PubMed ID: 26920599)
1. Rationale and design of POPular-TAVI: antiPlatelet therapy fOr Patients undergoing Transcatheter Aortic Valve Implantation.
Nijenhuis VJ; Bennaghmouch N; Hassell M; Baan J; van Kuijk JP; Agostoni P; van 't Hof A; Kievit PC; Veenstra L; van der Harst P; van den Heuvel AF; den Heijer P; Kelder JC; Deneer VH; van der Kley F; Onorati F; Collet JP; Maisano F; Latib A; Huber K; Stella PR; Ten Berg JM
Am Heart J; 2016 Mar; 173():77-85. PubMed ID: 26920599
[TBL] [Abstract][Full Text] [Related]
2. Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve: The ARTE (Aspirin Versus Aspirin + Clopidogrel Following Transcatheter Aortic Valve Implantation) Randomized Clinical Trial.
Rodés-Cabau J; Masson JB; Welsh RC; Garcia Del Blanco B; Pelletier M; Webb JG; Al-Qoofi F; Généreux P; Maluenda G; Thoenes M; Paradis JM; Chamandi C; Serra V; Dumont E; Côté M
JACC Cardiovasc Interv; 2017 Jul; 10(13):1357-1365. PubMed ID: 28527771
[TBL] [Abstract][Full Text] [Related]
3. The role of platelet reactivity assessment in dual antiplatelet prophylaxis after transcatheter aortic valve implantation.
Czerwińska-Jelonkiewicz K; Witkowski A; Dąbrowski M; Piotrowski W; Hryniewiecki T; Stępińska J
Arch Cardiovasc Dis; 2018 Apr; 111(4):233-245. PubMed ID: 29126843
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of Clopidogrel Loading in Patients Who Underwent Transcatheter Aortic Valve Implantation (from the BRAVO-3 Randomized Trial).
Nijenhuis VJ; Ten Berg JM; Hengstenberg C; Lefèvre T; Windecker S; Hildick-Smith D; Kupatt C; Van Belle E; Tron C; Hink HU; Colombo A; Claessen B; Sartori S; Chandrasekhar J; Mehran R; Anthopoulos P; Deliargyris EN; Dangas G
Am J Cardiol; 2019 May; 123(9):1494-1500. PubMed ID: 30826050
[TBL] [Abstract][Full Text] [Related]
5. Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation.
Brouwer J; Nijenhuis VJ; Delewi R; Hermanides RS; Holvoet W; Dubois CLF; Frambach P; De Bruyne B; van Houwelingen GK; Van Der Heyden JAS; Toušek P; van der Kley F; Buysschaert I; Schotborgh CE; Ferdinande B; van der Harst P; Roosen J; Peper J; Thielen FWF; Veenstra L; Chan Pin Yin DRPP; Swaans MJ; Rensing BJWM; van 't Hof AWJ; Timmers L; Kelder JC; Stella PR; Baan J; Ten Berg JM
N Engl J Med; 2020 Oct; 383(15):1447-1457. PubMed ID: 32865376
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Dual-antiplatelet Therapy to Mono-antiplatelet Therapy After Transcatheter Aortic Valve Implantation: Systematic Review and Meta-analysis.
Gandhi S; Schwalm JD; Velianou JL; Natarajan MK; Farkouh ME
Can J Cardiol; 2015 Jun; 31(6):775-84. PubMed ID: 25913473
[TBL] [Abstract][Full Text] [Related]
7. Anticoagulation with or without Clopidogrel after Transcatheter Aortic-Valve Implantation.
Nijenhuis VJ; Brouwer J; Delewi R; Hermanides RS; Holvoet W; Dubois CLF; Frambach P; De Bruyne B; van Houwelingen GK; Van Der Heyden JAS; Toušek P; van der Kley F; Buysschaert I; Schotborgh CE; Ferdinande B; van der Harst P; Roosen J; Peper J; Thielen FWF; Veenstra L; Chan Pin Yin DRPP; Swaans MJ; Rensing BJWM; van 't Hof AWJ; Timmers L; Kelder JC; Stella PR; Baan J; Ten Berg JM
N Engl J Med; 2020 Apr; 382(18):1696-1707. PubMed ID: 32223116
[TBL] [Abstract][Full Text] [Related]
8. Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation.
Ussia GP; Scarabelli M; Mulè M; Barbanti M; Sarkar K; Cammalleri V; Immè S; Aruta P; Pistritto AM; Gulino S; Deste W; Capodanno D; Tamburino C
Am J Cardiol; 2011 Dec; 108(12):1772-6. PubMed ID: 21907949
[TBL] [Abstract][Full Text] [Related]
9. Platelet reactivity in patients undergoing transcatheter aortic valve implantation.
Orvin K; Eisen A; Perl L; Zemer-Wassercug N; Codner P; Assali A; Vaknin-Assa H; Lev EI; Kornowski R
J Thromb Thrombolysis; 2016 Jul; 42(1):11-8. PubMed ID: 26695072
[TBL] [Abstract][Full Text] [Related]
10. Antithrombotic treatment in patients undergoing transcatheter aortic valve implantation (TAVI).
Nijenhuis VJ; Bennaghmouch N; van Kuijk JP; Capodanno D; ten Berg JM
Thromb Haemost; 2015 Apr; 113(4):674-85. PubMed ID: 25653053
[TBL] [Abstract][Full Text] [Related]
11. NOAC monotherapy in patients with concomitant indications for oral anticoagulation undergoing transcatheter aortic valve implantation.
Geis NA; Kiriakou C; Chorianopoulos E; Uhlmann L; Katus HA; Bekeredjian R
Clin Res Cardiol; 2018 Sep; 107(9):799-806. PubMed ID: 29644411
[TBL] [Abstract][Full Text] [Related]
12. High on-treatment platelet reactivity in transcatheter aortic valve implantation patients.
Polzin A; Schleicher M; Seidel H; Scharf RE; Merx MW; Kelm M; Zeus T
Eur J Pharmacol; 2015 Mar; 751():24-7. PubMed ID: 25641745
[TBL] [Abstract][Full Text] [Related]
13. Rationale and design of The Intracoronary Stenting and Antithrombotic Regimen-Testing of a six-week versus a six-month clopidogrel treatment Regimen In Patients with concomitant aspirin and oraL anticoagulant therapy following drug-Eluting stenting (ISAR-TRIPLE) study.
Fiedler KA; Byrne RA; Schulz S; Sibbing D; Mehilli J; Ibrahim T; Maeng M; Laugwitz KL; Kastrati A; Sarafoff N
Am Heart J; 2014 Apr; 167(4):459-465.e1. PubMed ID: 24655693
[TBL] [Abstract][Full Text] [Related]
14. Rationale and design of Non-antithrombotic Therapy After Transcatheter Aortic Valve Implantation (NAPT) Trial.
Inohara T; Otsuka T; Watanabe Y; Shirai S; Tada N; Yamanaka F; Ueno H; Ohno Y; Tabata M; Suzuyama H; Asami M; Yamawaki M; Izumo M; Yamasaki K; Nishina H; Fuku Y; Mizutani K; Yashima F; Yamamoto M; Hayashida K
Contemp Clin Trials; 2023 Nov; 134():107358. PubMed ID: 37852534
[TBL] [Abstract][Full Text] [Related]
15. Sex Differences in Outcomes After Transcatheter Aortic Valve Replacement: A POPular TAVI Subanalysis.
van Bergeijk KH; van Ginkel DJ; Brouwer J; Nijenhuis VJ; van der Werf HW; van den Heuvel AFM; Voors AA; Wykrzykowska JJ; Ten Berg JM
JACC Cardiovasc Interv; 2023 May; 16(9):1095-1102. PubMed ID: 37164609
[TBL] [Abstract][Full Text] [Related]
16. Pre-procedural dual antiplatelet therapy and bleeding events following transcatheter aortic valve implantation (TAVI).
Huczek Z; Kochman J; Grygier M; Parma R; Scislo P; Wilimski R; Ochala A; Lesiak M; Olasinska-Wisniewska A; Grabowski M; Mazurek T; Sibbing D; Filipiak KJ; Opolski G
Thromb Res; 2015 Jul; 136(1):112-7. PubMed ID: 26004748
[TBL] [Abstract][Full Text] [Related]
17. Antiplatelet Therapy in TAVI: Current Clinical Practice and Recommendations.
Magkoutis NA; Fradi S; Azmoun A; Ramadan R; Ben Ouanes S; Vavuranakis M; Vrachatis DA; Papaioannou TG; Tousoulis D; Ghostine S
Curr Pharm Des; 2016; 22(13):1888-95. PubMed ID: 26898915
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Platelet REACtivity After Transcatheter Aortic Valve Replacement: The REAC-TAVI Trial.
Jimenez Diaz VA; Tello-Montoliu A; Moreno R; Cruz Gonzalez I; Baz Alonso JA; Romaguera R; Molina Navarro E; Juan Salvadores P; Paredes Galan E; De Miguel Castro A; Bastos Fernandez G; Ortiz Saez A; Fernandez Barbeira S; Raposeiras Roubin S; Ocampo Miguez J; Serra Peñaranda A; Valdes Chavarri M; Cequier Fillat A; Calvo Iglesias F; Iñiguez Romo A
JACC Cardiovasc Interv; 2019 Jan; 12(1):22-32. PubMed ID: 30621974
[TBL] [Abstract][Full Text] [Related]
19. Comparison of dual antiplatelet therapy versus oral anticoagulation following transcatheter aortic valve replacement: A retrospective single-center registry analysis.
Holy EW; Kebernik J; Allali A; El-Mawardy M; Richardt G; Abdel-Wahab M
Cardiol J; 2017; 24(6):649-659. PubMed ID: 28497845
[TBL] [Abstract][Full Text] [Related]
20. Hyper-Response to Clopidogrel in Japanese Patients Undergoing Transcatheter Aortic Valve Implantation.
Watanabe Y; Kozuma K; Ishikawa S; Hosogoe N; Isshiki T
Int Heart J; 2016; 57(2):190-7. PubMed ID: 26973266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
